Presented by IMMUNOTEC

Investor Relations

Board of Directors

Immunotec’s Board of Directors leverages depth of business experience and acumen with solid network marketing experience to promote long-term growth for its independent Consultants. The members of the Board of Directors of Immunotec are:

  • James A. Northrop

    Mr. Northrop is the President and Chief Executive Officer of Immunotec. Mr. Northrop is a seasoned chief executive with a record of success in rapid growth situations, Mr. Northrop has impressive experience in the direct selling, consumer packaged goods, cosmetics, fashion and retail industries. He is well-known for his ability to see the essence of a business and position it for future growth. Mr. Northrop has acted as Chairman, Chief Executive Officer and President for a number of companies, including a direct sales company where his leadership significantly impacted profitability through development of the Hispanic market, expansion of the product line and establishment of a strong trust relationship with independent field representatives.

  • Dieter Beer

    Mr. Beer is the co-founder of Immunotec. Mr. Beer founded Immunotec Research Corp. with Dr. Gustavo Bounous and a team of medical researchers from McGill University in 1988. In 1996, Immunotec Research Corp. merged with Mr. Roberts’ company to form Immunotec. Earlier in his career, in 1961, Mr. Beer launched an electronics import business in Germany. As the exclusive agent and importer of leading electronics brands, he commercialized his own line of audio, hi fi and video equipment under the company name TEC. Mr. Beer then went on to purchase ORFA AG, a Swiss environmental and engineering company, and developed a fully automated recycling system that was licensed to companies such as Hitachi Zosen, Kawasaki Heavy Industries, ORFA Germany, and Ecoltecnica Italy. The launch of other ORFA projects in Europe, the Middle East and Asia followed. Mr. Beer has studied Economics, Electronics, International Law and Languages in Germany, England, France, and Spain.

  • Top of Page
  • Robert Dépatie

    Mr. Dépatie is the President and Chief Executive Officer of Vidéotron Ltd. a position he has held since June 2003. He joined Vidéotron Ltd. in December 2001 as Principal Vice President of Sales, Marketing and Customer Service. Prior to joining Vidéotron Ltd., Mr. Dépatie held many high level positions in the food distribution industry, such as President of Distributions alimentaires Le Marquis/Planters. From 1988 to 1996, he held various positions with H.J. Heinz Canada Ltd. Mr. Dépatie began his career in sales with Bessy’s Foods and Nabisco Canada. He serves as a Director of Cable Television Laboratories, Inc. and of CF Cable TV Inc. and Vidéotron (regional) Ltd.

  • Top of Page
  • Robert Henry

    Mr. Henry held a number of senior management positions, most recently, from 2004 to mid 2008, as CEO and Director of Arbonne International Inc, a US based Network Marketing Company with a billion dollars in sales, and previously, from 2000 to 2003, as CEO and Director of Mannatech, Incorporated (Nasdaq: MTEX), where he successfully turned around this company and returned it to profitability. He also held senior executive positions in many successful corporations, namely at Amway Corporation, Avon Products, Gryphon Investments and Hosiery Corporation of America. Mr. Henry served on many boards of directors of private and public companies, namely Purity Products, McCaffrey & McCall, Inc., Saatchi & Saatchi DFS, Inc. and National Media Corp. (NYSE). Mr. Henry holds a license from the New York Bar Association, a Juris Doctor from Brooklyn Law School in New York as well as a Bachelor of Science in Accounting from Hunter College in New York.

  • Top of Page
  • Alex Konigsberg, QC

    Mr. Konigsberg is a founding partner of the Montreal law firm Lapointe Rosenstein LLP, where his practice was focused on international commercial transactions. Mr. Konigsberg has lectured in over 40 countries to governmental and non governmental institutions, business groups, law faculties, legal and trade associations on the legal and business issues encountered in international commerce. In addition, Mr. Konigsberg is the author of over 70 articles on various legal and commercial issues as well as the author of the leading textbook on international franchising entitled “International Franchising”. He has experience on corporate boards and on corporate governance issues, having sat on the boards of several public and private companies.

  • Top of Page
  • Jean La Couture, FCA

    Mr. La Couture is the President of Huis Clos Ltd., a management and mediation firm. He is also the President of the “Regroupement des assureurs de personnes à charte du Québec”, a Quebec association of life insurers. Mr. La Couture currently serves on the Board of Directors of several other private and public companies, including Innergex Power Trust (listed on the TSX), Americ Disc. Inc., Maestro (real estate), Tecsult Inc. and Club Saint Denis, and is a director and the Chairman of the Audit Committee for Quebecor Inc., Quebecor Media Inc., Videotron Ltd., Sun Media Corporation and Groupe Pomerleau.

  • Top of Page
  • Charles L. Orr

    Mr. Orr has 43 years of experience in a variety of industries and distribution channels including financial services, information systems, dietary supplements, foods, roses, household products, skincare, and water filtration. From 1993 through 2000, Mr. Orr was President and Chief Executive Officer of Shaklee Corporation, which included the brand names of Harry and David, Jackson and Perkins, and Shaklee. Prior business associations include RCA, Xerox, Connecticut General, Southwestern Life, Continental Insurance, and Federated Investors. From 2000 to present, Mr. Orr has served as an advisor and board member to several private and public companies. Past board affiliations include Herbalife Ltd. (NYSE:HLF), Provident Mutual Life Insurance Company, Shaklee Corporation, the Direct Selling Association, the Direct Selling Education Foundation, Consumer Health Products Association and Shaklee Cares.

  • Top of Page
  • Richard Patte, CA

    Mr. Patte is the Executive Vice-President of Immunotec. Mr. Patte has over 35 years of experience in corporate financial management and organizational development. A chartered accountant, Mr. Patte was a partner of the accounting firms Jarrett, Goold & Elliott and Price Waterhouse. He later took his financial expertise to an international network marketing company where he was Chief Financial Officer. Mr. Patte gained insight into the production and marketing of natural health products as a director and officer of a Quebec research and development company and for a group of companies manufacturing and distributing dietary supplements.

  • Top of Page
  • Charles H. Roberts

    Mr. Roberts is the co-founder of Immunotec. In 1996, his company joined forces with Immunotec Research Corp., a company with 10 years of expertise in research on health promoting products, to form Immunotec. Immediately prior to founding Immunotec, Mr. Roberts was instrumental in the worldwide expansion of a network marketing company based in Montreal. Prior to that, Mr. Roberts started Descente Canada, which went on to become the supplier of sportswear to high profile sports teams such as the American, Canadian, Swiss, and Spanish Olympic ski teams.

  • Top of Page

Financial Statements

Click one of the links below to review Immunotec's consolidated financial statements.

2010
Period Ended April 30, 2010
Period Ended January 31, 2010
2009
Year Ended October 31, 2009
Period Ended July 31, 2009
Period Ended April 30, 2009
Period Ended January 31, 2009
2008
Year Ended October 31, 2008
Period Ended July 31, 2008
Period Ended April 30, 2008
Period Ended January 31, 2008
2007
Year Ended October 31, 2007
Period Ended July 31, 2007
Period Ended April 30, 2007
Period Ended January 31, 2007

Management Discussion and Analysis

Click one of the links below:

2010
Period Ended April 30, 2010
Period Ended January 31, 2010
2009
Year Ended October 31, 2009
Period Ended July 31, 2009
Period Ended April 30, 2009
Period Ended January 31, 2009
2008
Year Ended October 31, 2008
Period Ended July 31, 2008
Period Ended April 30, 2008
Period Ended January 31, 2008
2007
Year Ended October 31, 2007
Period Ended July 31, 2007
Period Ended April 30, 2007
Period Ended January 31, 2007

Press Releases

Click one of the following links to read one of Immunotec's press releases.

2010
Immunotec mourns passing of Chairman Alex Konigsberg
Q2-2010 - Period Ended April 30, 2010
Immunotec to Present at the World Cancer Congress Conference In Singapore
Immunotec Acquires Assets from Licensee in Mexico and Expands its Seamless Network
Immunotec Appoints Robert M. Henry as New Director
Q1-2010 - Period Ended January 31, 2010
Q4-2009 - Year Ended October 31, 2009
2009
Immunotec Announces commencement of IMN 1207 US Lung Cancer Study funded by Moffitt Cancer Center CCOP Research Base
Immunotec appoints Patrick Montpetit as Chief Financial Officer
Q3-2009 - Period Ended July 31, 2009
Immunotec Announces an Independent, Clinical Research Initiative at Beaumont Hospitals’ Hospital’s Community Clinical Oncology Program (CCOP).
Immunotec Inc. announces the closing of its Korean operations.
IMMUNOTEC announces important clinical research initiative: New study to be launched with the goal of improving the quality of the aging process.
Q2-2009 - Period Ended April 30, 2009
Election of New Director
Q1-2009 - Period Ended January 31, 2009
Q4-2008 - Year Ended October 31, 2008
2008
Immunotec Congratulates 2008 Nobel Prize Winner in Medicine, Dr. Luc Montagnier
Q3-2008 - Period Ended July 31, 2008
Oral Tolerability of Cysteine-Rich Protein Isolate (Immunocal) in Autism – A Pilot Study
Immunotec Inc. Announces New Chief Operating Officer
Q2-2008 - Period Ended April 30, 2008
Q1-2008 - Period Ended January 31, 2008
Q4-2007 - Year Ended October 31, 2007
Cysteine-Rich Protein Prevents Weight Loss in Lung Cancer Patients: A Promising Intervention Study
2007
Health Canada approves health claim for Immunocal
Immunotec Inc. announces appointment of President & CEO James A. Northrop
Q3-2007 - Period Ended July 31, 2007
Immunotec Inc. announces retirement of President and CEO C.H. (Chuck) Roberts
Q2-2007 - Period Ended April 30, 2007
Q1-2007 - Period Ended January 31, 2007
Immunotec Inc. to Commence Trading on the TSX Venture Exchange

Annual Report

Click here for the 2009 Annual Report.

Fact Sheets

Click one of the links below:

2010
Period Ended January 31, 2010

Corporate Presentations

Click one of the links below:

2010
Period Ended January 31, 2010